Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-11-07 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ESTISSAC (10190), Aube
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SEL PHARMACIE PETIT : revenue, balance sheet and financial ratios
SEL PHARMACIE PETIT is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ESTISSAC (10190),
this company of category PME
shows in 2025 a net income positive of 157 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SEL PHARMACIE PETIT (SIREN 879266781)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
157 331 €
138 178 €
170 259 €
145 060 €
123 591 €
42 036 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SEL PHARMACIE PETIT generates positive net income of 157 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 42 k€ -> 157 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
157 331 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 95%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
94.776%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.716%
Solvency indicators evolution SEL PHARMACIE PETIT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
736.933
374.302
220.257
159.803
123.894
94.776
Financial autonomy
10.283
17.828
27.567
33.27
39.716
44.716
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
94.782025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average-8 pts over 3 years
In 2025, the debt ratio of SEL PHARMACIE PETIT (94.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.72%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average+8 pts over 3 years
In 2025, the financial autonomy of SEL PHARMACIE PETIT (44.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SEL PHARMACIE PETIT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
Customer payment term (days)
161
171
115
0
0
0
Supplier payment term (days)
960
658
496
0
0
0
Positioning of SEL PHARMACIE PETIT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SEL PHARMACIE PETIT is estimated at
2 499 221 €
(range 1 695 983€ - 3 921 622€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1695k€2499k€3921k€
2 499 221 €Range: 1 695 983€ - 3 921 622€
NAF 5 année 2025
Valuation method used
Net Income Multiple
157 331 €
×
15.9x
=2 499 222 €
Range: 1 695 984€ - 3 921 623€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SEL PHARMACIE PETIT with other companies in the same sector:
Frequently asked questions about SEL PHARMACIE PETIT
What is the revenue of SEL PHARMACIE PETIT ?
The revenue of SEL PHARMACIE PETIT is not publicly disclosed (confidential accounts filed with INPI).
Is SEL PHARMACIE PETIT profitable?
Yes, SEL PHARMACIE PETIT generated a net profit of 157 k€ in 2025.
Where is the headquarters of SEL PHARMACIE PETIT ?
The headquarters of SEL PHARMACIE PETIT is located in ESTISSAC (10190), in the department Aube.
Where to find the tax return of SEL PHARMACIE PETIT ?
The tax return of SEL PHARMACIE PETIT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SEL PHARMACIE PETIT operate?
SEL PHARMACIE PETIT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart